Literature DB >> 20882066

Association between NMDA receptor subunit 2b gene polymorphism and Alzheimer's disease in Chinese Han population in Shanghai.

Chao Chen1, Xia Li, Tao Wang, Hai-Hong Wang, Yi Fu, Lei Zhang, Shi-Fu Xiao.   

Abstract

OBJECTIVE: N-methyl-D-aspartate (NMDA) receptor has been indicated to be involved in the pathogenesis of Alzheimer's disease (AD). The NMDA receptor subunit 2b (NR2B) has attracted more attention due to its characteristic distribution and selective reduction in AD brain. The present study aimed to explore the association between NMDA gene polymorphism and AD.
METHODS: A total of 63 AD patients and 68 normal controls in Shanghai city were employed in this study. Genotype of C2664T variant (rs1806201) in the exon13 of GRIN2B gene was determined by gene sequencing.
RESULTS: Among AD patients, 15 (23.6%) subjects were identified as C/C genotype, and 35 (55.6%) were identified as C/T genotype. The left 13 (20.6%) subjects were identified as T/T genotype. In normal controls, 15 (22.1%) subjects were identified as C/C genotype, 39 (57.4%) as C/T genotype and 14 (20.6%) as T/T genotype. The distribution frequency of neither GRIN2B C2664T genotype (P=0.895) nor allele (P=0.790) was significantly different between AD patients and normal controls, even when the subjects were stratified by gender and age of disease onset in AD patients.
CONCLUSION: The results suggest that there is no relation between GRIN2B C2664T polymorphism and AD in Chinese Han population of Shanghai City.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20882066      PMCID: PMC5560356          DOI: 10.1007/s12264-010-0729-2

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN: 1995-8218            Impact factor:   5.203


  28 in total

1.  Association analysis for NMDA receptor subunit 2B (GRIN2B) genetic variants and psychopathology and clozapine response in schizophrenia.

Authors:  C J Hong; Y W Yu; C H Lin; C Y Cheng; S J Tsai
Journal:  Psychiatr Genet       Date:  2001-12       Impact factor: 2.458

2.  Association analysis for the genetic variants of the NMDA receptor subunit 2b and Alzheimer's disease.

Authors:  Shih-Jen Tsai; Hsiu-Chih Liu; Tsung-Yun Liu; Chih-Ya Cheng; Chen-Jee Hong
Journal:  Dement Geriatr Cogn Disord       Date:  2002       Impact factor: 2.959

Review 3.  Use of genetic variation as biomarkers for Alzheimer's disease.

Authors:  Christiane Reitz; Richard Mayeux
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

Review 4.  What is 'early onset dementia'?

Authors:  Koho Miyoshi
Journal:  Psychogeriatrics       Date:  2009-06       Impact factor: 2.440

5.  Association between NR2B subunit gene (GRIN2B) promoter polymorphisms and sporadic Alzheimer's disease in the North Chinese population.

Authors:  Hanqiu Jiang; Jianping Jia
Journal:  Neurosci Lett       Date:  2008-10-25       Impact factor: 3.046

6.  Polymorphisms in the N-methyl-D-aspartate receptor 1 and 2B subunits are associated with alcoholism-related traits.

Authors:  Catrin Wernicke; Jerzy Samochowiec; Lutz G Schmidt; Georg Winterer; Michael Smolka; Jolanta Kucharska-Mazur; Jan Horodnicki; Jürgen Gallinat; Hans Rommelspacher
Journal:  Biol Psychiatry       Date:  2003-11-01       Impact factor: 13.382

7.  Amyloid beta oligomers induce Ca2+ dysregulation and neuronal death through activation of ionotropic glutamate receptors.

Authors:  Elena Alberdi; M Victoria Sánchez-Gómez; Fabio Cavaliere; Alberto Pérez-Samartín; José Luis Zugaza; Ramón Trullas; María Domercq; Carlos Matute
Journal:  Cell Calcium       Date:  2010-01-12       Impact factor: 6.817

8.  Association analysis of GRIN2B, encoding N-methyl-D-aspartate receptor 2B subunit, and Alzheimer's disease.

Authors:  Davide Seripa; Maria Giovanna Matera; Marilisa Franceschi; Alessandra Bizzarro; Francesco Paris; Leandro Cascavilla; Monica Rinaldi; Francesco Panza; Vincenzo Solfrizzi; Antonio Daniele; Carlo Masullo; Bruno Dallapiccola; Alberto Pilotto
Journal:  Dement Geriatr Cogn Disord       Date:  2008-02-26       Impact factor: 2.959

9.  GluN2B subunit-containing NMDA receptor antagonists prevent Abeta-mediated synaptic plasticity disruption in vivo.

Authors:  Neng-Wei Hu; Igor Klyubin; Roger Anwyl; Roger Anwy; Michael J Rowan
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-16       Impact factor: 11.205

Review 10.  Rationale for and use of NMDA receptor antagonists in Parkinson's disease.

Authors:  Penelope J Hallett; David G Standaert
Journal:  Pharmacol Ther       Date:  2004-05       Impact factor: 12.310

View more
  4 in total

1.  Integrated Bioinformatics Analysis to Identify Alternative Therapeutic Targets for Alzheimer's Disease: Insights from a Synaptic Machinery Perspective.

Authors:  Hamid Ceylan
Journal:  J Mol Neurosci       Date:  2021-08-19       Impact factor: 3.444

2.  Identification of a Novel Rat NR2B Subunit Gene Promoter Region Variant and Its Association with Microwave-Induced Neuron Impairment.

Authors:  Li-Feng Wang; Da-Wei Tian; Hai-Juan Li; Ya-Bing Gao; Chang-Zhen Wang; Li Zhao; Hong-Yan Zuo; Ji Dong; Si-Mo Qiao; Yong Zou; Lu Xiong; Hong-Mei Zhou; Yue-Feng Yang; Rui-Yun Peng; Xiang-Jun Hu
Journal:  Mol Neurobiol       Date:  2015-04-28       Impact factor: 5.590

3.  Potential involvement of GRIN2B encoding the NMDA receptor subunit NR2B in the spectrum of Alzheimer's disease.

Authors:  Virginia Andreoli; Elvira Valeria De Marco; Francesca Trecroci; Rita Cittadella; Gemma Di Palma; Antonio Gambardella
Journal:  J Neural Transm (Vienna)       Date:  2013-12-01       Impact factor: 3.575

4.  Opposite roles of NMDA receptors in relapsing and primary progressive multiple sclerosis.

Authors:  Silvia Rossi; Valeria Studer; Alessandro Moscatelli; Caterina Motta; Giancarlo Coghe; Giuseppe Fenu; Stacy Caillier; Fabio Buttari; Francesco Mori; Francesca Barbieri; Maura Castelli; Valentina De Chiara; Fabrizia Monteleone; Raffaele Mancino; Giorgio Bernardi; Sergio E Baranzini; Maria G Marrosu; Jorge R Oksenberg; Diego Centonze
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.